20434-92-8 Usage
General Description
2-(4-Hydroxyphenyl)-2H-isoquinolin-1-one, also known as berberine, is a natural alkaloid found in various plants, including goldenseal and Chinese goldthread. 2-(4-Hydroxyphenyl)-2H-isoquinolin-1-one has a yellow color and is often used in traditional medicine for its anti-inflammatory, antimicrobial, and antioxidative properties. Berberine has been studied for its potential in treating various conditions, such as diabetes, high cholesterol, and gastrointestinal infections. It also has shown promising results in the treatment of certain types of cancer. Additionally, berberine has been used as a dye and as a flavoring agent in food and beverages.
Check Digit Verification of cas no
The CAS Registry Mumber 20434-92-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,4,3 and 4 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 20434-92:
(7*2)+(6*0)+(5*4)+(4*3)+(3*4)+(2*9)+(1*2)=78
78 % 10 = 8
So 20434-92-8 is a valid CAS Registry Number.
InChI:InChI=1/C15H11NO2/c17-12-7-5-10(6-8-12)14-9-11-3-1-2-4-13(11)15(18)16-14/h1-9,17H,(H,16,18)
20434-92-8Relevant articles and documents
TREATMENT OF DISEASES BY EPIGENETIC REGULATION
-
Paragraph 0429; 0430, (2013/11/05)
The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of cancer, including NUT midline carcinoma, Burkitt's Lymphoma, Acute Myelogenous Leukemia, and Multiple Myeloma; autoimmune or inflammatory diseases or conditions, and sepsis.
PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF COMPLEX DISEASES AND THEIR DELIVERY BY INSERTABLE MEDICAL DEVICES
-
Page/Page column 68-69, (2008/06/13)
The present invention relates to polyphenol-like compounds that are useful for inhibiting VCAM-1 expression, MCP-1 expression and/or SMC proliferation in a mammal. The disclosed compounds are useful for regulating markers of inflammatory conditions, including vascular inflammation, and for treatment and prevention of inflammatory and cardiovascular diseases and related disease states.